[Photo by Element5 Digital on Unsplash]
While the presidential election could have a significant influence on the pharma sector, arguably more important is who gains control of Congress. A blue sweep that hands Biden the presidency and gives Democrats control over the Senate will likely expand the Affordable Care Act, but the degree of drug-pricing reform will depend on the strength of the Democratic majority.
Read the whole story on our sister site, Drug Discovery & Development
The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at [email protected].
Tell Us What You Think!